DOV, US2600031080

Dover stock gains on TraceIQ launch and $189.88 close

Published on 09/03/2026 at 11:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Dover stock is trading around $189.88 after Systech launched TraceIQ for pharma traceability on September 2, 2026. The latest quarter also showed $2.74 EPS, ahead of estimates.

Architektur-Render im Gastronomiebedarf mit Lieferbeutel im Ausstellungsbereich
Architektur-Render im Gastronomiebedarf mit Lieferbeutel zum Thema DoorDash Lieferung, ISIN US2600031080, neutrales Tageslicht, Illustration mit AI erstellt.

Dover Corporation stock (US2600031080) closed at $189.88 on September 1, 2026, after Systech, part of Dover, launched TraceIQ for pharmaceutical supply chains on September 2, 2026. The move left the stock with a market capitalization of $25.57 billion and a 52-week range of $158.97 to $237.54.

TraceIQ adds a fresh catalyst

According to StreetInsider, Systech said TraceIQ is already in production with customers and was shown at the Healthcare Distribution Alliance Traceability Seminar from August 31 to September 2, 2026. For Dover, the detail matters because the platform links compliance, traceability and AI-assisted analytics in one product push.

MarketBeat said Dover reported $2.74 in quarterly EPS on July 23, 2026, versus consensus of $2.72, and revenue rose 6.8 percent from the same quarter a year earlier. Those figures set the fundamental backdrop for the new product launch.

Profitability still supports the story

MarketBeat also shows a forward P/E ratio of 17.80, a dividend yield of 1.11 percent and 2026 sales of $8.09 billion in its company profile. The same page lists net income of $1.09 billion and a net margin of 13.48 percent, which helps explain why the stock still attracts a moderate buy consensus.

For investors, the comparison is simple: the stock is down 2.7 percent from the start of 2026, yet the latest quarter still beat EPS estimates by $0.02. That mix of a softer year-to-date chart and solid earnings execution is the key tension around Dover today.

Go deeper

Dover revenue, margin and TraceIQ in one view

The latest quarter and the TraceIQ launch point in the same direction: Dover is pairing stable profitability with product-level execution in pharma traceability.

Traceability is the product angle

Systech, a Dover subsidiary, described TraceIQ as a platform for identifying data errors, resolving supply chain exceptions and supporting operational decisions with AI-assisted investigation. That is a narrower but more concrete product story than a broad industrial profile.

Stock near the upper half

Dover stock was quoted at $189.88 on September 1, 2026, against a 52-week range of $158.97 to $237.54 and a market capitalization of $25.57 billion. Tradegate showed DOV at EUR 163.05 on September 3, 2026, with a 5-day change of -0.52 percent and a year-to-date move of -3.08 percent.

Dover stock facts

  • Company: Dover Corporation
  • ISIN: US2600031080
  • Ticker: DOV
  • Trading venue: NYSE
  • Price (as of September 1, 2026, 03:58 PM): $189.88 USD
  • Market capitalization: $25.57 billion (as of September 1, 2026)
  • Sector / Industry: Industrials / Machinery
  • Index membership: S&P 500

Disclaimer...

en | US2600031080 | DOV | boerse | 70048105 | bgmi